About

Maarten Beelen is a pioneering researcher at the forefront of robotic vitreoretinal surgery, dedicated to transforming the precision and safety of delicate eye procedures that push the boundaries of human capability. His work spans surgical robotics, retinal vein occlusion treatment, and intraocular drug delivery, establishing him as a leading figure in next-generation ophthalmic surgery. Beelen's most celebrated contribution is his involvement in the first-in-human study of intraocular robotic surgery (2018, 215 citations), a landmark achievement demonstrating that robot-assisted procedures within the eye are both safe and viable. Building on this foundation, he pioneered robotic cannulation of occluded retinal veins in porcine models and advanced the treatment of retinal vein occlusion — a leading cause of vision loss in adults over 50 — through direct intraluminal injection of ocriplasmin. His 2021 first-in-human robot-assisted subretinal drug delivery study (67 citations) further showcased robotics' potential for accessing previously unreachable anatomical targets. Through randomized controlled trials comparing robotic and manual techniques for membrane peeling procedures, Beelen has rigorously validated robotic surgery's clinical feasibility. His cumulative body of work, totaling over 580 citations, has fundamentally shaped the evidence base for surgical robotics in ophthalmology.

Research Focus

Key Achievements

11
H-Index
18
Papers
628
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
First-in-human study of the safety and viability of intraocular robotic surgery
215 citations · 2018
📈 Most Prolific Year: 2018 (4 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: University of Oxford, Prysmian Group (Netherlands), Eindhoven University of Technology, Systems Technology (United States)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago